| Literature DB >> 25759556 |
Akihiko Sakatani1, Yoshinori Doi1, Takaaki Matsuda1, Yasutaka Sasai1, Naohiro Nishida1, Megumi Sakamoto1, Naoto Uenoyama1, Yoshiya Matsumoto1, Kazuo Kinoshita1.
Abstract
Peginterferon is a key drug used to treat chronic viral hepatitis that is known for causing various side effects. Side effects occurring immediately after administration include headache, nausea, and influenza-like symptoms, such as fever and joint pain. However, reports of anaphylactic shock are extremely rare. Here we report a patient with protracted anaphylaxis who suffered shock symptoms after peginterferon α-2a administration for chronic hepatitis C. Although the patient improved temporarily with shock treatment, symptoms of anaphylaxis recurred. As peginterferon is often administered on an outpatient basis, it is important to recognize life-threatening side effects that may develop in a protracted manner.Entities:
Keywords: Anaphylactic shock; Anaphylaxis; Chronic hepatitis C; Peginterferon α-2a; Protracted anaphylaxis
Mesh:
Substances:
Year: 2015 PMID: 25759556 PMCID: PMC4351238 DOI: 10.3748/wjg.v21.i9.2826
Source DB: PubMed Journal: World J Gastroenterol ISSN: 1007-9327 Impact factor: 5.742